Anttila Verneri, Nyholt Dale R, Kallela Mikko, Artto Ville, Vepsäläinen Salli, Jakkula Eveliina, Wennerström Annika, Tikka-Kleemola Päivi, Kaunisto Mari A, Hämäläinen Eija, Widén Elisabeth, Terwilliger Joseph, Merikangas Kathleen, Montgomery Grant W, Martin Nicholas G, Daly Mark, Kaprio Jaakko, Peltonen Leena, Färkkilä Markus, Wessman Maija, Palotie Aarno
Biomedicum Helsinki, Research Program in Molecular Medicine, University of Helsinki, 00290 Helsinki, Finland.
Am J Hum Genet. 2008 May;82(5):1051-63. doi: 10.1016/j.ajhg.2008.03.003.
Here, we present the results of two genome-wide scans in two diverse populations in which a consistent use of recently introduced migraine-phenotyping methods detects and replicates a locus on 10q22-q23, with an additional independent replication. No genetic variants have been convincingly established in migraine, and although several loci have been reported, none of them has been consistently replicated. We employed the three known migraine-phenotyping methods (clinical end diagnosis, latent-class analysis, and trait-component analysis) with robust multiple testing correction in a large sample set of 1675 individuals from 210 migraine families from Finland and Australia. Genome-wide multipoint linkage analysis that used the Kong and Cox exponential model in Finns detected a locus on 10q22-q23 with highly significant evidence of linkage (LOD 7.68 at 103 cM in female-specific analysis). The Australian sample showed a LOD score of 3.50 at the same locus (100 cM), as did the independent Finnish replication study (LOD score 2.41, at 102 cM). In addition, four previously reported loci on 8q21, 14q21, 18q12, and Xp21 were also replicated. A shared-segment analysis of 10q22-q23 linked Finnish families identified a 1.6-9.5 cM segment, centered on 101 cM, which shows in-family homology in 95% of affected Finns. This region was further studied with 1323 SNPs. Although no significant association was observed, four regions warranting follow-up studies were identified. These results support the use of symptomology-based phenotyping in migraine and suggest that the 10q22-q23 locus probably contains one or more migraine susceptibility variants.
在此,我们展示了在两个不同人群中进行的两项全基因组扫描结果。在这两项研究中,通过持续运用最近引入的偏头痛表型分析方法,检测并重复验证了位于10q22 - q23上的一个基因座,且有额外的独立重复验证。在偏头痛研究中,尚未有基因变异被确凿证实,尽管已有多个基因座被报道,但无一得到一致的重复验证。我们在来自芬兰和澳大利亚的210个偏头痛家庭的1675名个体的大样本集中,运用了三种已知的偏头痛表型分析方法(临床最终诊断、潜在类别分析和性状成分分析),并进行了稳健的多重检验校正。在芬兰人群中,使用Kong和Cox指数模型进行的全基因组多点连锁分析在10q22 - q23上检测到一个基因座,具有高度显著的连锁证据(女性特异性分析中,在103 cM处的LOD值为7.68)。澳大利亚样本在同一基因座(100 cM)处的LOD评分为3.50,芬兰的独立重复研究也是如此(在102 cM处的LOD评分为2.41)。此外,之前报道的位于8q21、14q21、18q12和Xp21上的四个基因座也得到了重复验证。对与10q22 - q23连锁的芬兰家庭进行的共享片段分析确定了一个以101 cM为中心、长度为1.6 - 9.5 cM的片段,该片段在95%的受影响芬兰人中显示出家族内同源性。我们用1323个单核苷酸多态性(SNP)对该区域进行了进一步研究。尽管未观察到显著关联,但确定了四个值得后续研究的区域。这些结果支持在偏头痛研究中使用基于症状学的表型分析,并表明10q22 - q23基因座可能包含一个或多个偏头痛易感变异。